Journal article
A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).
Authors
Karp DD; Lee SJ; Shaw Wright GL; Johnson DH; Johnston MR; Goodman GE; Clamon GH; Okawara GS; Marks R; Ruckdeschel JC
Journal
Journal of Clinical Oncology, Vol. 28, No. 15_suppl, pp. cra7004–cra7004
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.cra7004
ISSN
0732-183X